Healthcare provider profile · identity verified

Emmanuel Plenos Dizon, M.D.

Internal Medicine · DETROIT, MI · NPI 1447328984

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	638	198
Amlodipine Besylate	Amlodipine Besylate	512	157
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	327	59
Losartan Potassium	Losartan Potassium	317	104
Metformin Hcl	Metformin Hcl	265	76
Omeprazole	Omeprazole	255	71
Lisinopril	Lisinopril	228	70
Metoprolol Succinate	Metoprolol Succinate	208	71
Levothyroxine Sodium	Levothyroxine Sodium	206	63
Gabapentin	Gabapentin	202	53
Tamsulosin Hcl	Tamsulosin Hcl	179	55
Simvastatin	Simvastatin	158	47
Fluticasone Propionate	Fluticasone Propionate	155	67
Albuterol Sulfate Hfa	Albuterol Sulfate	138	36
Eliquis	Apixaban	135	38
Hydrochlorothiazide	Hydrochlorothiazide	135	44
Alprazolam	Alprazolam	132	24
Jardiance	Empagliflozin	128	44
Acetaminophen-Codeine	Acetaminophen With Codeine	120	22
Spironolactone	Spironolactone	101	29
Ibuprofen	Ibuprofen	100	28
Ozempic	Semaglutide	99	18
Pantoprazole Sodium	Pantoprazole Sodium	95	28
Metoprolol Tartrate	Metoprolol Tartrate	92	31
Nifedipine Er	Nifedipine	89	30
Famotidine	Famotidine	80	29
Donepezil Hcl	Donepezil Hcl	76	21
Carvedilol	Carvedilol	75	26
Allopurinol	Allopurinol	72	24
Atenolol	Atenolol	72	19
Oxycodone Hcl	Oxycodone Hcl	71	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	68	68
Rosuvastatin Calcium	Rosuvastatin Calcium	67	25
Furosemide	Furosemide	63	27
Xarelto	Rivaroxaban	59	14
Tizanidine Hcl	Tizanidine Hcl	57	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	27
Trulicity	Dulaglutide	52	suppressed
Meloxicam	Meloxicam	51	13
Trazodone Hcl	Trazodone Hcl	51	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	50	suppressed
Potassium Chloride	Potassium Chloride	48	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	17
Pregabalin	Pregabalin	47	11
Tramadol Hcl	Tramadol Hcl	47	11
Ventolin Hfa	Albuterol Sulfate	47	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	16
Shingrix	Varicella-Zoster Ge/As01b/Pf	46	40
Sertraline Hcl	Sertraline Hcl	45	suppressed
Diclofenac Sodium	Diclofenac Sodium	42	17
Valacyclovir	Valacyclovir Hcl	42	16
Hydroxyzine Hcl	Hydroxyzine Hcl	41	11
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Mirtazapine	Mirtazapine	38	13
Clopidogrel	Clopidogrel Bisulfate	37	15
Methocarbamol	Methocarbamol	37	12
Montelukast Sodium	Montelukast Sodium	37	14
Escitalopram Oxalate	Escitalopram Oxalate	36	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	35	suppressed
Metformin Hcl Er	Metformin Hcl	34	12
Chlorthalidone	Chlorthalidone	31	suppressed
Glipizide	Glipizide	31	suppressed
Hydrocortisone	Hydrocortisone	31	13
Triamcinolone Acetonide	Triamcinolone Acetonide	31	15
Alcohol Prep Pads	Alcohol Antiseptic Pads	29	suppressed
Ezetimibe	Ezetimibe	28	11
Hydralazine Hcl	Hydralazine Hcl	28	11
Buspirone Hcl	Buspirone Hcl	27	suppressed
Celecoxib	Celecoxib	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	12
Wegovy	Semaglutide	27	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	26	13
Finasteride	Finasteride	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Nystatin	Nystatin	24	suppressed
Diazepam	Diazepam	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Prednisone	Prednisone	23	16
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Creon	Lipase/Protease/Amylase	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Pulmicort Flexhaler	Budesonide	20	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	15
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	16	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Carisoprodol	Carisoprodol	15	suppressed
Colchicine	Colchicine	15	suppressed
Felodipine Er	Felodipine	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Folic Acid	Folic Acid	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Naproxen	Naproxen	15	11
Ramipril	Ramipril	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Desonide	Desonide	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Asa-Butalb-Caffeine-Codeine	Codeine/Butalbital/Asa/Caffein	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Naloxone Hcl	Naloxone Hcl	12	suppressed
Restasis	Cyclosporine	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error